Latest News
PFF IN THE NEWS
POSTED BY PULMONARY FIBROSIS FOUNDATION ON 1/9/2012
Recent posts
- 5/14 Pulmonary Fibrosis Foundation Launches Partnership with Inspire Online Support Community >
- 5/10 Stony Brook, NYU in Deal with Drug Firm >
- 5/4 Fibrogen Announces Promising Preliminary Data from an Open-Label Phase 2 Study to Evaluate the Safety and Efficacy of Fg-3019 in Individuals with Idiopathic Pulmonary Fibrosis (IPF) and Provides Program Update >
- 4/7 France's Transparency Commission (CT) Issues Favorable Opinion for Reimbursement of Esbriet® (pirfenidone) >
- 3/16 First Fibrosis Across Organs Symposium Provides Direction for Future Research and Treatment Efforts in Fibrotic Diseases >
- 3/15 Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) >
- 2/28 Broadway’s Best Gather To Raise Funds And Awareness For The Pulmonary Fibrosis Foundation >
- 1/9 Pulmonary Fibrosis Foundation Conference to Drive New Research >
Archive
- May 2012 (3)
- April 2012 (1)
- March 2012 (2)
- February 2012 (1)
- January 2012 (1)
- December 2011 (2)
- October 2011 (9)
- September 2011 (6)
- August 2011 (2)
- July 2011 (6)
Sort by Category
- Medical News (60)
- News Story (31)
- Patient Stories (15)
- PFF in the News (11)
- Advocacy (11)
- Interviews (8)
- Breakthroughs (7)
- PFF News (7)
- Research News (3)
